InnovaRx Innova Health Strategies

E55.0

Rickets, active

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 12 never code together
E55.0code
Excludes1
E55code
Excludes1
  • adult osteomalacia (M83.-)M83.-
  • osteoporosis (M80.-)M80.-
  • sequelae of rickets (E64.3)E64.3
E50-E64block
Excludes2
  • nutritional anemias (D50-D53)D50-D53
E00-E89chapter
Excludes1
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 3
E55.0code
Inclusion terms
  • Infantile osteomalacia
  • Juvenile osteomalacia
E00-E89chapter
Notes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 8
  • Morbus — see also Disease
    • angelicus, anglorum E55.0
  • Tetany (due to) R29.0
    • associated with rickets E55.0
  • Avitaminosis (multiple) E56.9
  • Calciferol (vitamin D) deficiency E55.9
  • Disease, diseased — see also Syndrome
    • English (rickets) E55.0
  • Scurvy, scorbutic E54
  • Rickets (active) (acute) (adolescent) (chest wall) (congenital) (current) (infantile) (intestinal) E55.0
  • Rosary, rachitic E55.0
Alongside this code 1 same parent — E55
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

RX08HCC87

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
E55
Block
E50-E64
Siblings
1

Present FY2024–FY2027.